Published in Cancer Weekly, December 19th, 2006
"We also demonstrate the in vivo properties of Ad5-based vectors that contain the B-group Ad serotype 35 fiber...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.